Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Return on Sales (2016 - 2025)

Phibro Animal Health has reported Return on Sales over the past 14 years, most recently at 0.07% for Q4 2025.

  • Quarterly results put Return on Sales at 0.07% for Q4 2025, up 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.06% (up 6.0% YoY), and the annual figure for FY2025 was 0.04%, up 5.0%.
  • Return on Sales for Q4 2025 was 0.07% at Phibro Animal Health, up from 0.07% in the prior quarter.
  • Over the last five years, Return on Sales for PAHC hit a ceiling of 0.08% in Q4 2021 and a floor of 0.04% in Q2 2024.
  • Median Return on Sales over the past 5 years was 0.03% (2021), compared with a mean of 0.03%.
  • Biggest five-year swings in Return on Sales: decreased -5bps in 2022 and later rose 9bps in 2025.
  • Phibro Animal Health's Return on Sales stood at 0.08% in 2021, then crashed by -61bps to 0.03% in 2022, then crashed by -83bps to 0.01% in 2023, then soared by 102bps to 0.01% in 2024, then soared by 613bps to 0.07% in 2025.
  • The last three reported values for Return on Sales were 0.07% (Q4 2025), 0.07% (Q3 2025), and 0.05% (Q2 2025) per Business Quant data.